The Impact of Pharmacist - Led Mobile Application on Medication Adherence and Efficacy in Chronic Kidney Disease Patients
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Chronic Kidney Diseases
- Sponsor
- Cairo University
- Enrollment
- 86
- Locations
- 1
- Primary Endpoint
- Change in medication adherence
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
The aim of the study is to assess the impact of pharmacist led mobile application on adherence and efficacy of medication in chronic kidney disease patients
Detailed Description
This is a prospective randomized two group pharmacist-led interventional study that will be conducted in a private nephrology clinic. The study will involve introduction of the mobile phone applications to chronic kidney disease patients to improve their adherence to the prescribed medications. Recruited patients will be randomly divided in two groups; intervention group and control group, with baseline evaluation of outcomes to be measured. Control group will be provided with usual care. Intervention group will be provided in addition to the usual care, with an access to the mobile application after a simple training for app usage. Both groups will be followed for a period of 3 months. The study will include the development, validation and the testing for evaluating the specially designed mobile application.
Investigators
Shaza Gamal Abdel Fattah Ali Mohamed
Teaching Assistant
Cairo University
Eligibility Criteria
Inclusion Criteria
- •Stages 2-5 of chronic kidney disease
- •Ownership of android smart phone compatible with the application
- •Poly-pharmacy
Exclusion Criteria
- •On dialysis due to loss of kidney function
- •Pregnancy due to altered physiology
Outcomes
Primary Outcomes
Change in medication adherence
Time Frame: Change from baseline at 3 months
Using a medication adherence questionnaire.
Secondary Outcomes
- Change in estimated glomerular filtration rate/ creatinine clearance(Change from baseline at 3 months)
- Change in systolic and diastolic blood pressure(Change from baseline at 3 months)
- Change in mobile application usability and acceptability by patients(Change from baseline at 3 months)
- Change in HbA1c(Change from baseline at 3 months)